The Drug Olympics: FDA To Test Consumer Comprehension Of Composite Endpoints
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA will explain to study participants that just as a decathlon athlete may not win at the long jump, the shot put, or the 50-yard dash but may still be the best overall, a composite score in a clinical trial may not guarantee a drug’s efficacy against any given symptom that is a component of the whole.
You may also be interested in...
DTC Rx Drug Ad Study No. 30: Do Market Claims Impact Perception?
FDA to assess whether claims such as '#1 prescribed' affect consumer views of drug product; project to cost $529,742. Chart notes price tag for 18 other DTC studies.
FDA’s Biggest DTC Advertising Study Eyes Online Promotion
The agency has 11 research projects under way, including a $2 million study of online Rx drug promotion; pharma spending on direct-to-consumer advertising declined in 2012 with biggest spends on Cymbalta and Cialis ads.